Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 2 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |
US-based, early-stage biopharma developing microbiome-derived zwitterionic polysaccharide-based therapeutics for autoimmune diseases
1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 2 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |